Click for full image >>
is a biopharmaceutical company focused on the development of
novel treatments for B-cell malignancies and autoimmune diseases.
TG Therapeutics, Inc. Announces Clinical Data Presentations at the Upcoming 51st Annual Meeting of the American Society of Clinical Oncology
TG Therapeutics, Inc. Announces First Quarter 2015 Financial Results and Business Update
3 Columbus Circle, 15th Floor, New York, NY 10019 - P:212.554.4484 - Email Us
Web Site Development by Tidal Media Group